| Financial Year |
March 31 2023 |
| Monetary Funds |
3,753,653,240.92 |
| Held-for-trading Financial Assets |
491,788,421.75 |
| Notes Receivable |
59,694,929.33 |
| Accounts Receivable |
2,979,436,034.30 |
| Advances to Suppliers |
243,952,021.25 |
| Other Receivables |
24,098,592.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,116,084,494.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
157,270,338.63 |
| Other Current Assets |
41,361,684.91 |
| Total Current Assets |
9,373,438,356.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
181,245,532.64 |
| Investment Properties |
2,934,454.08 |
| Fixed Assetes |
1,517,521,135.35 |
| Under-construction Projects |
144,723,652.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
274,746,669.74 |
| R&D expenses |
3,638,829.58 |
| Goodwill |
28,940,970.72 |
| Long-Term Deferred and Prepaid Expenses |
6,148,601.67 |
| Deferred Income Tax Assets |
93,546,935.17 |
| Other Non-Current Assets |
31,965,308.07 |
| Sub-Total of Non-Current Assets |
3,913,050,463.69 |
| Total Assets |
13,286,488,820.26 |
| Short-Term Loans |
1,344,528,594.48 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,010,195,519.20 |
| Accounts Payable |
2,556,348,253.54 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
142,694,838.73 |
| Taxes Payable |
41,498,110.25 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
176,644,592.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
246,754,008.36 |
| Other Current Liabilities |
5,030,709.44 |
| Sub-Total of Current Liabilities |
7,621,431,214.56 |
| Long-term Loans |
395,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
65,682,992.60 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
681,022,181.89 |
| Total Liabilities |
8,302,453,396.45 |
| Paid-In Capital(Or Share Stock) |
695,995,979.00 |
| Capital Surplus |
1,583,112,961.86 |
| Surplus Reserve |
83,799,384.83 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,287,940,264.55 |
| Minority Stockholder's Interest |
1,319,033,386.53 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,665,002,037.28 |
| Owner's Equity（Stockholder's Equity） |
4,984,035,423.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,286,488,820.26 |
